Clinical trial registry record

Effect of Infections and Global DNA Methylation on Frailty Trajectories in Hospitalized Older Patients (INFRAGEN)

A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Unknown.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated May 28, 2024.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT06430073
Last registry update
May 28, 2024
Status
Unknown
Phase
Phase not reported
Sponsor
University Hospital of Ferrara
Enrollment
340
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
OBSERVATIONAL
Evidence population
Human clinical study registration
Participants
340
Population
ALL · 70 Years
Duration
2024-05-20 to 2026-03-01
Intervention
Comparator
Not reported
Outcomes measured
Change in frailty index from pre-admission to hospital discharge — From 14 days before admission to hospital discharge…; Change in Clinical Frailty Scale from pre-admission to hospital discharge — From 14 days before admission to hospital d…; Difference in in-hospital mortality between inpatients with vs without infections with systemic inflammation — From 14…; Difference in the length of hospital stay between inpatients with vs without infections with systemic inflammation — Fr…; Difference in the global DNA methylation between individuals with stable vs worsened frailty during the hospital stay.…; Difference in telomere length between individuals with stable vs worsened frailty during the hospital stay — From 14 da…; Change in frailty index from hospital discharge to 3-month follow-up — From hospital discharge until 3 months after hos…; Change in Clinical Frailty Scale from hospital discharge to 3-month follow-up — From hospital discharge until 3 months…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 80% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Epigenetic alterations · 80%Title contains controlled term: dna methylation. Title supplies longevity context: frailty, frail. Study type is explicitly identified as OBSERVATIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

epigenetic alterations
Open primary sourceExport JSON